Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Jade Biosciences
Jade Biosciences Outlines Key 2026 Objectives and Strategy to Advance Pipeline of Potentially Best-in-Class Monoclonal Antibodies Across Multiple Autoimmune Diseases Ahead of the 44th Annual J.P. Morgan Healthcare Conference
January 05, 2026
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences Announces $45 Million Private Placement
December 15, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update
November 13, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of Nephrology Kidney Week 2025
November 08, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences to Participate in Upcoming Conferences
November 03, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences Announces New Data Presentations for JADE101 at the American Society of Nephrology Kidney Week 2025
October 17, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences Announces JADE201, a Potentially Best-in-Class Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody in Development for Autoimmune Diseases
October 07, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences Announces $135 Million Private Placement
October 07, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences Announces First Cohort Dosed in Phase 1 Healthy Volunteer Clinical Trial of JADE101, a Novel and Potentially Best-in-Class Anti-APRIL Monoclonal Antibody Being Evaluated for the Treatment of IgA Nephropathy
September 02, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences to Participate in Upcoming Conferences
August 25, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Update
August 13, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences to Participate in Two Upcoming Investor Conferences
July 08, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences Appoints Brad Dahms as Chief Financial Officer
July 01, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences Presents JADE101 Preclinical Data at the 62nd European Renal Association Congress Demonstrating Potential for Best-in-Class Profile in IgA Nephropathy
June 09, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences to Present New Preclinical Data on JADE101 at the 62nd European Renal Association Congress
June 02, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences Reports First Quarter 2025 Financial Results and Provides Corporate Update
May 14, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences to Participate in the 2025 Jefferies Global Healthcare Conference
May 13, 2025
From
Jade Biosciences
Via
GlobeNewswire
Tickers
JBIO
Jade Biosciences Completes Closing of Merger with Aerovate Therapeutics and Previously Announced Private Placement of Approximately $300 Million
April 28, 2025
From
Jade Biosciences
Via
GlobeNewswire
Jade Biosciences to Participate in TD Cowen’s 45th Annual Health Care Conference and Jefferies Biotech on the Beach Summit
February 12, 2025
From
Jade Biosciences
Via
GlobeNewswire
Jade Biosciences to Participate in Upcoming Investor Conferences
November 13, 2024
From
Jade Biosciences
Via
GlobeNewswire
Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement
October 31, 2024
From
Jade Biosciences
Via
GlobeNewswire
Tickers
AVTE
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
